Ultragenyx Pharmaceutical Inc. (RARE)
NASDAQ: RARE · Real-Time Price · USD
16.10
-0.68 (-4.05%)
At close: Oct 30, 2026, 4:00 PM EST
16.04
-0.06 (-0.37%)
Pre-market: Nov 2, 2026, 4:20 AM EST
Ultragenyx Pharmaceutical Market Cap
Ultragenyx Pharmaceutical has a market cap or net worth of $1.58 billion as of October 30, 2026. It is the 7,562nd most valuable company in the world and the 1,940th biggest in the United States. Its market cap has decreased by 52.53% in one year.
Market Cap
1.58B
Enterprise Value
2.35B
1-Year Change
-52.53%
Global Rank
Country Rank
#1,940 United States
Category
ChartMarket Cap Chart
Since January 31, 2014, Ultragenyx Pharmaceutical's market cap has increased from $1.19B to $1.58B, an increase of 33.10%. That is a compound annual growth rate of 2.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 1.59B | -28.47% |
| Dec 31, 2025 | 2.22B | -42.88% |
| Dec 31, 2024 | 3.88B | -1.06% |
| Dec 29, 2023 | 3.93B | 20.90% |
| Dec 30, 2022 | 3.25B | -43.33% |
| Dec 31, 2021 | 5.73B | -32.17% |
| Dec 31, 2020 | 8.45B | 242.48% |
| Dec 31, 2019 | 2.47B | 12.20% |
| Dec 31, 2018 | 2.20B | 11.33% |
| Dec 29, 2017 | 1.98B | -31.24% |
| Dec 30, 2016 | 2.87B | -34.05% |
| Dec 31, 2015 | 4.36B | 211.25% |
| Dec 31, 2014 | 1.40B | 17.73% |
| Jan 31, 2014 | 1.19B | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Replimune Group | 1.67B |
| Kailera Therapeutics | 1.67B |
| Novavax | 1.66B |
| Mineralys Therapeutics | 1.61B |
| UroGen Pharma | 1.60B |
| Nanobiotix | 1.60B |
| Immunocore Holdings | 1.57B |
| Structure Therapeutics | 1.56B |